Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

NCT01180049

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mercy Research Institute Miami, Florida, United States
  • Veterans Affairs New Jersey Healthcare System-Hematology/Oncology Section (111) East Orange, New Jersey, United States
  • Mercy Clinic Oklahoma Communities dba Mercy Clinic Oncology/Hematology-McAuley Oklahoma City, Oklahoma, United States
  • Mercy Hospital Oklahoma City-Oncology Infusion Oklahoma City, Oklahoma, United States
View all 31 locations
View Trial Details
Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00392691

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Completed

A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents

NCT02745769

Conditions
Advanced Cancer, Colonic Diseases, Colorectal Cancer, +20 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marseille, France
View Trial Details

Related conditions